drugset / Trial / NCT02236026

A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers

NCT02236026

Phase 1 Completed 44 enrolled Population Council Parexel · collab
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the study is to evaluate the effect of Nestorone (NES) administered as an bolus injection on the corrected QT interval using Fridericia's formula (QTcF).

Timeline

Start
2014-09
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule
Subject Segesterone Acetate Small molecule

Indications

No indication recorded.